Azalea Therapeutics
About Azalea Therapeutics
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Seed and Series A T: - FT: Seed and Series A |
A: 82000000 MR: - FA: $82 million FAN: 82000000 |
D: 2025-11-04 FD: 2025-11-04 |
5 investors |
Growth Metrics
Team & Leadership
Jenny Hamilton
Co-founder, President and Chief Executive Officer
Paul Westberg
Chief Business Officer
Connor Tsuchida
Scientific Cofounder
Abdullah Syed
Scientific co-founder
Jennifer Doudna
Nobel Laureate in Chemistry; Professor; Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences
Justin Eyquem
Principal Investigator
Recent News
Azalea Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- azaleatx.com
- Industries
- Biotechnology / Healthcare
- Company Size
- ~260 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro